100 Hip Replacements Performed with Total Joint Orthopedics’ Platform Acetabular System

The first 100 procedures using Total Joint Orthopedics’ Platform Acetabular System have been successfully completed.
 
The Platform Acetabular System received 510(k) market clearance from the U.S. Food and Drug Administration on September 23, 2022.
 
“We are thrilled with the addition of the Platform Cup to our hip portfolio, offering surgeons a state-of-the-art solution designed to enhance patient outcomes. Allowing for future compatibility with Aurum Technology, the Platform Cup strengthens our commitment to eliminating Cobalt Chrome from total joint replacement,” said Andrew Morris, TJO’s VP of Strategy.
 
According to Total Joint Orthopedics, the Platform Acetabular System comprises the best design features from the most successful acetabular constructs and offers the potential for exceptional patient outcomes and survivorship.¹ The Platform Cup’s Ti-Coat has an ideal scratch fit for initial fixation and simplified acetabular preparation, allowing for smooth insert placement, with visual and tactile verification of the final seating. Offering a unique insert for each cup size, the Platform Acetabular System addresses critical concerns about stability, wear, fixation, and the maximum range of motion.
 
Michael J. Morris, MD of Joint Implant Surgeons in New Albany, Ohio, recently implanted the 100th Platform Cup.
 
“The cup embodies TJO’s surgeon- and patient-centric mission. The preparation, instrumentation, ease of insertion of both shell and liner, coupled with the initial fixation and robust bone ingrowth of the Ti-Coat, offers a reproducible and reliable component choice for hip arthroplasty,” said Dr. Morris.

Reference:
¹ Law, J., Hofmann, A.A., Myers, A., & Grant, A. Minimum 5-year follow up of porous coated cementless total hip arthroplasty. J Orthop Muscular Syst Res. 2019;2:09. DOI: 10.29011/ JOMSR-09.100009